A three-drug combination to treat BRAF-mutant cancers.

about

A three-drug combination to treat BRAF-mutant cancers.

Item

http://www.wikidata.org/entity/Q46172410

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A three-drug combination to treat BRAF-mutant cancers.

@en

A three-drug combination to treat BRAF-mutant cancers.

@nl

type

Item

label

A three-drug combination to treat BRAF-mutant cancers.

@en

A three-drug combination to treat BRAF-mutant cancers.

@nl

prefLabel

A three-drug combination to treat BRAF-mutant cancers.

@en

A three-drug combination to treat BRAF-mutant cancers.

@nl

P1476

A three-drug combination to treat BRAF-mutant cancers.

@en

P2093

Ari J Firestone

http://www.w3.org/2001/XMLSchema#string

Jeff Settleman

http://www.w3.org/2001/XMLSchema#string

P2860

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.

Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance

The impact of intra-clonal heterogeneity on the treatment of multiple myeloma.

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors

Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer.

Managing drug resistance in cancer: lessons from HIV therapy

P2888

nm.4382

P304

913-914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.4382

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28777790

http://www.w3.org/2001/XMLSchema#string